Effects of fluid resuscitation with synthetic colloids or crystalloids alone on shock reversal, fluid balance, and patient outcomes in patients with severe sepsis: A prospective sequential analysis

Critical Care Medicine

Volumn 40, Issue 9, 2012, Pages 2543-2551

  Bayer, Ole ^a   Reinhart, Konrad ^a,d   Kohl, Matthias ^b   Kabisch, Björn ^a   Marshall, John ^c   Sakr, Yasser ^a   Bauer, Michael ^a,d   Hartog, Christiane ^a,d   Schwarzkopf, Daniel ^d   Riedemann, Niels ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b FURTWANGEN UNIVERSITY   (Germany)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

acute kidney injury; coagulopathy; colloids; crystalloids; plasma volume expanders; shock

Indexed keywords

CREATININE; GELATIN; HETASTARCH;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CENTRAL VENOUS PRESSURE; COLLOID; CRYSTALLOID; DISEASE SEVERITY; FEMALE; FLUID BALANCE; FLUID RESUSCITATION; FLUID THERAPY; HEMODYNAMICS; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; SEPSIS; SEPTIC SHOCK; SEQUENTIAL ANALYSIS;

AGED; COHORT STUDIES; COLLOIDS; FEMALE; FLUID THERAPY; FOLLOW-UP STUDIES; GELATIN; HEMODYNAMICS; HETASTARCH; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; ISOTONIC SOLUTIONS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RESUSCITATION; RISK ASSESSMENT; SEPSIS; SHOCK, SEPTIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME; WATER-ELECTROLYTE IMBALANCE;

EID: 84865477013     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318258fee7     Document Type: Article

References (38)

1. Finfer S, Liu B, Taylor C, et al: SAFE TRIPS Investigators: Resuscitation fluid use in critically ill adults: An international cross-sectional study in 391 intensive care units.
2. Rackow EC, Falk JL, Fein IA, et al: Fluid resuscitation in circulatory shock: A comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Crit Care Med 1983; 11:839-850
3. Shoemaker WC: Comparison of the relative effectiveness of whole blood transfusions and various types of fluid therapy in resuscitation. Crit Care Med 1976; 4:71-78
4. Trof RJ, Sukul SP, Twisk JW, et al: Greater cardiac response of colloid than saline fluid loading in septic and non-septic critically ill patients with clinical hypovolaemia. Intensive Care Med 2010; 36:697-701
5. Lamke LO, Liljedahl SO: Plasma volume changes after infusion of various plasma expanders. Resuscitation 1976; 5:93-102
6. Wiedemann HP, Wheeler AP, Bernard GR, et al: National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network: Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006; 354:2564-2575
7. Rivers E, Nguyen B, Havstad S, et al: Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377
8. Jones AE, Shapiro NI, Trzeciak S, et al: Emergency Medicine Shock Research Network (EMShockNet) Investigators: Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: A randomized clinical trial. JAMA 2010; 303:739-746
9. Mikkelsen ME, Miltiades AN, Gaieski DF, et al: Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med 2009; 37:1670-1677
10. Barochia AV, Cui X, Vitberg D, et al: Bundled care for septic shock: An analysis of clinical trials. Crit Care Med 2010; 38:668-678
11. Wills BA, Nguyen MD, Ha TL, et al: Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med 2005; 353:877-889
12. Finfer S, Bellomo R, Boyce N, et al: SAFE Study Investigators: A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350:2247-2256
13. Brunkhorst FM, Engel C, Bloos F, et al: German Competence Network Sepsis (SepNet): Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358:125-139
14. Maitland K, Kiguli S, Opoka RO, et al: FEAST Trial Group: Mortality after fluid bolus in African children with severe infection. N Engl J Med 2011; 364:2483-2495
15. Akech S, Gwer S, Idro R, et al: Volume expansion with albumin compared to gelofusine in children with severe malaria: Results of a controlled trial. PLoS Clin Trials 2006; 1:e21
16. Choi PT, Yip G, Quinonez LG, et al: Crystalloids vs. colloids in fluid resuscitation: A systematic review. Crit Care Med 1999; 27:200-210
17. Perel P, Roberts I: Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2011; 16:CD000567
18. Zarychanski R, Turgeon AF, Fergusson DA, et al: Renal outcomes and mortality following hydroxyethyl starch resuscitation of critically ill patients: Systematic review and meta-analysis of randomized trials: ATTENTION: The analysis and conclusions of this article are being revised by the authors. This is due to the journal Anesthesia and Analgesia's retraction of a paper by Dr. Joachim Boldt, an author in seven of the studies analyzed in this review. As such, the editors of Open Medicine recommend interpreting this review with extreme caution until Zarychanski et al. publish a new analysis and interpretation in Open Medicine. For more information, see Anesthesia and Analgesia's press release. Open Med 2009; 3:e196-e209
19. Dart AB, Mutter TC, Ruth CA, et al: Hydroxyethyl starch (HES) versus other fluid therapies: Effects on kidney function. Cochrane Database Syst Rev 2010:CD007594
20. Bayer O, Reinhart K, Sakr Y, et al: Renal effects of synthetic colloids and crystalloids in patients with severe sepsis: A prospective sequential comparison. Crit Care Med 2011; 39:1335-1342
21. Wilkes MM, Navickis RJ, Sibbald WJ: Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: A meta-analysis of postoperative bleeding. Ann Thorac Surg 2001; 72:527-533; discussion 534
22. de Jonge E, Levi M: Effects of different plasma substitutes on blood coagulation: A comparative review. Crit Care Med 2001; 29:1261-1267
23. Auwerda JJ, Leebeek FW, Wilson JH, et al: Acquired lysosomal storage caused by frequent plasmapheresis procedures with hydroxyethyl starch. Transfusion 2006; 46:1705-1711
24. Schmidt-Hieber M, Loddenkemper C, Schwartz S, et al: Hydrops lysosomalis generalisatus-an underestimated side effect of hydroxyethyl starch therapy? Eur J Haematol 2006; 77:83-85
25. Schortgen F, Lacherade JC, Bruneel F, et al: Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: A multicentre randomised study. Lancet 2001; 357:911-916
26. Schabinski F, Oishi J, Tuche F, et al: Effects of a predominantly hydroxyethyl starch (HES)-based and a predominantly non HES-based fluid therapy on renal function in surgical ICU patients. Intensive Care Med 2009; 35:1539-1547
27. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874
28. Mehta RL, Kellum JA, Shah SV, et al: Acute Kidney Injury Network: Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11:R31
29. Levick JR, Michel CC: Microvascular fluid exchange and the revised Starling principle. Cardiovasc Res 2010; 87:198-210
30. Schortgen F, Girou E, Deye N, et al: CRYCO Study Group: The risk associated with hyperoncotic colloids in patients with shock. Intensive Care Med 2008; 34:2157-2168
31. Westphal M, James MF, Kozek-Langenecker S, et al: Hydroxyethyl starches: Different products-different effects. Anesthesiology 2009; 111:187-202
32. Kief H, Engelbart K, Arnold G, et al: [Vacuolar reabsorption of native and digested gelatin (so-called osmotic nephrosis)]. Virchows Arch B Cell Pathol 1968; 1:240-250
33. Dickenmann M, Oettl T, Mihatsch MJ: Osmotic nephrosis: Acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes. Am J Kidney Dis 2008; 51:491-503
34. Schick MA, Isbary TJ, Schlegel N, et al: The impact of crystalloid and colloid infusion on the kidney in rodent sepsis. Intensive Care Med 2010; 36:541-548
35. Hüter L, Simon TP, Weinmann L, et al: Hydroxyethylstarch impairs renal function and induces interstitial proliferation, macrophage infiltration and tubular damage in an isolated renal perfusion model. Crit Care 2009; 13:R23
36. Levy MM, Dellinger RP, Townsend SR, et al: The Surviving Sepsis Campaign: Results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med 2010; 36:222-231
37. Vincent JL, Sakr Y, Sprung CL, et al: Sepsis Occurrence in Acutely Ill Patients Investigators: Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med 2006; 34:344-353
38. Reinhart K, Meisner M, Brunkhorst FM: Markers for sepsis diagnosis: What is useful? Crit Care Clin 2006; 22:503-519